Article
OX40, OX40L and Autoimmunity: a Comprehensive Review.
Clinical reviews in allergy & immunology - 1 Jun 2016
Webb Gwilym J, Hirschfield Gideon M, Lane Peter J L
Abstract excerpt
The tumour necrosis factor receptor OX40 (CD134) is activated by its cognate ligand OX40L (CD134L, CD252) and functions as a T cell co-stimulatory molecule. OX40-OX40L interactions have been proposed as a potential therapeutic target for treating autoimmunity. OX40 is expressed on activated T cells, and in the mouse at rest on regulatory T cells (Treg). OX40L is found on antigen-presenting cells, activated T...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
